Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Change in Receivables (2022 - 2025)

Coeptis Therapeutics Holdings (COEP) has 3 years of Change in Receivables data on record, last reported at $52500.0 in Q3 2025.

  • For Q3 2025, Change in Receivables changed N/A year-over-year to $52500.0; the TTM value through Sep 2025 reached $52500.0, changed N/A, while the annual FY2023 figure was -$8075.0, 200.0% down from the prior year.
  • Change in Receivables reached $52500.0 in Q3 2025 per COEP's latest filing, up from -$8075.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $52500.0 in Q3 2025 and bottomed at -$8075.0 in Q1 2023.
  • Average Change in Receivables over 3 years is $17500.0, with a median of $8075.0 recorded in 2022.